cbdMD (YCBD) Gross Profit Growth (3y) (2020 - 2025)
cbdMD (YCBD) Gross Profit Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 0.95% |
| 10 | cbdMD | 4.60 Mn | 1.22 Mn | 3.00 Mn | -5.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.60% |
| Sep 30, 2025 | -17.63% |
| Jun 30, 2025 | -21.86% |
| Mar 31, 2025 | -22.84% |
| Dec 31, 2024 | -12.02% |
| Sep 30, 2024 | -24.68% |
| Jun 30, 2024 | -22.06% |
| Mar 31, 2024 | -31.86% |
| Dec 31, 2023 | -26.33% |
| Sep 30, 2023 | -17.70% |
| Jun 30, 2023 | -17.66% |
| Mar 31, 2023 | -15.55% |
| Sep 30, 2022 | 642.29% |
| Jun 30, 2022 | 5.34% |
| Mar 31, 2022 | 233.73% |
| Dec 31, 2021 | 155.27% |
| Sep 30, 2021 | 172.65% |
| Jun 30, 2021 | 50.92% |
| Mar 31, 2021 | 47.20% |
| Dec 31, 2020 | 168.51% |